Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

"An Overview of Global Regulatory Trends in the Nutraceutical Industry – April 2013"

Excerpt from article:
"* Generally the goals of nutraceutical regulation have been focused on safety and labeling with lesser emphasis (as compared to pharmaceuticals) on product claims and intended use. This is achieved through Good Manufacturing Practice (GMP) regulations and a recent increase in enforcement.
* Consumers are largely responsible for determining the usefulness and value offered by nutraceutical products, although regulatory agencies are increasingly enforcing industry requirements that call for nutraceutical companies to track adverse events.
* There is consensus among nutraceutical companies that increased regulation related to quality and safety will benefit the industry, and help mitigate the risk of regulatory backlash if scrupulous players engage in abusive practices and are left unchecked.
* Greater enforcement of GMP regulations are likely to drive further consolidation in the relatively young, fragmented industry as those lacking proper scale are unable to comply with the greater emphasis on regulation or make the necessary investments to become compliant across multiple jurisdictions."

"The Nutraceutical Market
Bourne Partners released an April 2013 Nutraceutical Sector Report (free download) that put the global nutraceutical market at $142 billion in 2011. With an estimated growth rate of 6.4% (CAGR), the market is expected to reach $204.8 billion by 2017. Growth is being driven by favorable demographics, increases in disposable income, rising healthcare costs and an increasingly robust OTC market. In developing nations, the middle classes are growing, which translates to increased disposable income because of typically regressive tax structures. Also, developing nations are increasingly becoming the preferred source for cheaper raw material supply found in many nutraceutical products."

Article at:
http://bournepartners.wordpress.com/2013/04/22/an-overview-of-global-regulatory-trends-in-the-nutraceutical-industry-april-2013/